Journal of Nippon Medical School: Vol.69 No.4 page.379

Journal of Nippon Medical School

Select Language
in Japanese < > in English

Full Text of this Article

in Japanese PDF (32K)

ArticleTitle The Efficacy of Donepezil in Alzheimer's Disease

AuthorList Takao Ito and Hiroshi Yamadera

Affiliation Department of Neuropsychiatry, Tama Nagayama Hospital, Nippon Medical School

Language JA

Volume 69

Issue 4

Year 2002

Page 379-382

Received January 22, 2002

Accepted March 5, 2002

Keywords donepezil, Alzheimer's Disease

Abstract Several studies have reported the efficacy of donepezil (a cholinesterase inhibitor) in patients with Alzheimer's Disease, not only for memory disturbances but also for psychotic and behavioral disturbances.
We have experienced one such case that was a 74-year-old female patient with Alzheimer's Disease. Donepezil remarkably improved, for the most part, these symptoms in this case.
The scale of Mini-Mental State Examination (MMSE) was improved from 21/30 to 26/30, and the Alzheimer's Disease Assessment Scale (ADAS) was improved from 21.7/70 to 16.3/70. It took about 8 weeks of treatment with donepezil to achieve these results, although some adverse effects associated with the use of donepezil were found in this case. It became difficult for the nursing staff to give care because of hyperactivity and self-assertion.
However, the relationship between donepezil and these behavioral disturbances was not clear.
This case indicates that donepezil may exacerbate symptoms in Alzheimer's Disease patients who have psychotic and behavioral problems.
From a clinical point of view, we concluded that donepezil is therapeutically efficacious for Alzheimer's Disease sufferers, but that some problems still exist.

Correspondence to Takeo Ito, Department of Neuropsychiatry, Tama Nagayama Hospital, Nippon Medical School, 1-7-1 Nagayama, Tama-shi, Tokyo 206-8512, Japan

ArticleTitle	The Efficacy of Donepezil in Alzheimer's Disease
AuthorList	Takao Ito and Hiroshi Yamadera
Affiliation	Department of Neuropsychiatry, Tama Nagayama Hospital, Nippon Medical School
Language	JA
Volume	69
Issue	4
Year	2002
Page	379-382
Received	January 22, 2002
Accepted	March 5, 2002
Keywords	donepezil, Alzheimer's Disease
Abstract	Several studies have reported the efficacy of donepezil (a cholinesterase inhibitor) in patients with Alzheimer's Disease, not only for memory disturbances but also for psychotic and behavioral disturbances. We have experienced one such case that was a 74-year-old female patient with Alzheimer's Disease. Donepezil remarkably improved, for the most part, these symptoms in this case. The scale of Mini-Mental State Examination (MMSE) was improved from 21/30 to 26/30, and the Alzheimer's Disease Assessment Scale (ADAS) was improved from 21.7/70 to 16.3/70. It took about 8 weeks of treatment with donepezil to achieve these results, although some adverse effects associated with the use of donepezil were found in this case. It became difficult for the nursing staff to give care because of hyperactivity and self-assertion. However, the relationship between donepezil and these behavioral disturbances was not clear. This case indicates that donepezil may exacerbate symptoms in Alzheimer's Disease patients who have psychotic and behavioral problems. From a clinical point of view, we concluded that donepezil is therapeutically efficacious for Alzheimer's Disease sufferers, but that some problems still exist.
Correspondence to	Takeo Ito, Department of Neuropsychiatry, Tama Nagayama Hospital, Nippon Medical School, 1-7-1 Nagayama, Tama-shi, Tokyo 206-8512, Japan